manufacturing

News

FDA rejects ImmunityBio’s bladder cancer drug

Shares in ImmunityBio were in freefall today after it revealed the FDA had rejected its marketing application for Anktiva as a treatment for bladder cancer.

News

Baxter will sell biopharma unit to investors for $4.25bn

Baxter has reached an agreement to sell its contract development and manufacturing organisation (CDMO) business to a pair of private equity companies, raising $4.25 billio

News

Wave of strikes hit GSK’s UK manufacturing

GSK was able to avert industrial action at some of its UK facilities last year after agreeing a

R&D

The pharma trends leading to higher demand for CDMOs

Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.

R&D